INSIGHTS ON DRUG DEVELOPMENT

  • The Pharma Trends You Need To Know: A CDMO’s Perspective

    Companies must understand how today’s new pharmaceutical landscape is causing a dramatic shift in how we plan for and execute drug development and manufacturing.

  • Overcoming Challenges Associated With Biologic Drug Formulation And Development

    Biologic manufacturing subjects the formulation to different stresses and conditions that may compromise quality and stability. Recently, the requirement for the development of subcutaneous formulations for high dose drugs, such as monoclonal antibodies, at high protein concentrations has created additional challenges, including degradation. Read about the options provided by wearable technology offers new alternatives that were not previously possible due to historically binding parameters for formulators.

  • Five Reasons To Consider Outsourcing Analytical Testing

    Leveraging external experts for analytical input provides a cost-effective route to the latest instrumentation, robust and precise measurement, and reliable data interpretation. 

  • S.U.B. Enhancements For High-Density Perfusion Cultures

    This study presents how strategic enhancements to the sparge and agitation systems of Thermo Scientific HyPerforma S.U.B.s have revealed the potential for a three- to four-fold improvement in mixing and mass transfer performance compared to legacy S.U.B. designs.

  • Supporting The Transformation Of The Patient Experience With IASO

    IASO supports stakeholders who are responsible for bringing innovation to market in the form of combination products for oncology.  

More Insights On Drug Development

DRUG DEVELOPMENT SOLUTIONS

  • Zetasizer Ultra Nanoparticle Size Analyzer
    Zetasizer Ultra Nanoparticle Size Analyzer

    Nanoparticle size analyzer with zeta potential measurements.

    The new Zetasizer Ultra is our most advanced system for the measurement of particle and molecular size, particle charge and particle concentration, and represents the most intelligent and flexible instrument in the Zetasizer range.

  • Ultracentrifuge
    Ultracentrifuge

    The CP100WX is a general-purpose Ultracentrifuge with outstanding performance up to 100,000 rpm assisting in a wide range of separation protocols in involving proteins, DNA, RNA, metal nano-colloids, and more. Reliable and efficient the Hitachi CP100WX features a Rotor Life Management (RLM) system to automatically maintain rotor logging history maximizing rotor life.

  • CFS 1500™ Capsule Filling and Sealing Machine

    The CFS 1500™ is a capsule filling and sealing machine and is a part of the Lonza Engine™ equipment portfolio, which was created to support bioavailability enhancement, encapsulation and early-phase clinical development technologies. To learn more about its capabilities and specifications, download the brochure.

  • Container Closure Integrity Testing

    Successful drug product development should integrate formulation, manufacturing process, primary packaging, device and delivery to the patient. Lonza’s Drug Product Services (DPS) offering delivers a holistic approach to DP development that anticipates and prevents problems early, and ensures the result is a product that is fit for purpose.

  • Mini Microcentrifuge  - Prism™ LN-C1801
    Mini Microcentrifuge - Prism™ LN-C1801

    The user-friendly Prism™ Mini is a reliable, compact, and economical personal microcentrifuge ideal for quick spins that can be used for a wide range of molecular biology protocols. Prism™ Mini works out of the box with a maintenance-free drive system and advanced design providing quiet operation and proper ventilation protecting temperature-sensitive samples. Prism™ Mini includes two (2) quick release interchangeable rotors with a max speed up to 6000 RPM.

More Drug Development Solutions